The active drug in Ozempic, semaglutide, is also the active drug in the medication Wegovy. And Wegovy is approved for weight management. The dosage of Wegovy for weight management is similar to ...

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

[O]ral semaglutide 14 mg (or flexible dosing, in PIONEER 7) was generally more effective at improving multiple cardiometabolic risk factors — including HbA 1c, [body weight], SBP, and LDL ...